Streptozocin

In the US, Streptozocin (streptozocin systemic) is a member of the drug class alkylating agents and is used to treat Pancreatic Cancer.

US matches:

Scheme

Rec.INN

ATC (Anatomical Therapeutic Chemical Classification)

L01AD04

CAS registry number (Chemical Abstracts Service)

0018883-66-4

Chemical Formula

C8-H15-N3-O7

Molecular Weight

265

Therapeutic Category

Cytostatic alkylating agent

Chemical Name

D-Glucose, 2-deoxy-2-[[(methylnitrosoamino)carbonyl]amino]-

Foreign Names

  • Streptozocinum (Latin)
  • Streptozocin (German)
  • Streptozocine (French)
  • Estreptozocina (Spanish)

Generic Names

  • Streptozocin (OS: USAN)
  • Streptozocine (OS: DCF)
  • NRRL 2697 (IS)
  • NRRL 3125 (IS)
  • Streptozotocin (IS)
  • U 9889 (IS: Upjohn)

Brand Names

  • Zanosar
    CSP, France; IFET, Greece; Pfizer, Canada; Pharmacia, Israel; Teva, United States

International Drug Name Search

Glossary

TermDefinition
DCFDénomination Commune Française
ISInofficial Synonym
OSOfficial Synonym
Rec.INNRecommended International Nonproprietary Name (World Health Organization)
USANUnited States Adopted Name

Click for further information on drug naming conventions and International Nonproprietary Names.

Important Notice: The Drugs.com international database is in BETA release. This means it is still under development and may contain inaccuracies. It is not intended as a substitute for the expertise and judgement of your physician, pharmacist or other healthcare professional. It should not be construed to indicate that the use of any medication in any country is safe, appropriate or effective for you. Consult with your healthcare professional before taking any medication.

Hide
(web1)